Cel-Sci
CVM
#9903
Rank
NZ$68.57 M
Marketcap
NZ$8.58
Share price
-0.52%
Change (1 day)
-76.91%
Change (1 year)

Earnings for Cel-Sci (CVM)

Earnings in 2025 (TTM): -NZ$41.89 Million

According to Cel-Sci 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$45.92 Million, an increase over its 2023 earnings that were of -NZ$52.42 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cel-Sci from 1986 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$41.89 Million-8.78%
2024 -NZ$45.92 Million-12.41%
2023 -NZ$52.42 Million-12.87%
2022 -NZ$60.17 Million-3.42%
2021 -NZ$62.3 Million13.44%
2020 -NZ$54.92 Million11.28%
2019 -NZ$49.35 Million179.81%
2018 -NZ$17.64 Million-48.72%
2017 -NZ$34.4 Million-16.23%
2016 -NZ$41.06 Million-23.63%
2015 -NZ$53.77 Million-5.47%
2014 -NZ$56.88 Million198.49%
2013 -NZ$19.06 Million
2010 -NZ$22.24 Million
2004 -NZ$7.52 Million12.38%
2003 -NZ$6.69 Million-16.59%
2002 -NZ$8.02 Million-59.28%
2001 -NZ$19.69 Million23.17%
2000 -NZ$15.99 Million20.12%
1999 -NZ$13.31 Million13.24%
1998 -NZ$11.76 Million-20%
1997 -NZ$14.7 Million46.55%
1996 -NZ$10.03 Million34.88%
1995 -NZ$7.44 Million2.38%
1994 -NZ$7.26 Million68%
1993 -NZ$4.33 Million78.57%
1992 -NZ$2.42 Million180%
1991 -NZ$0.87 Million25%
1990 -NZ$0.7 Million-0%
1989 -NZ$0.7 Million-71.43%
1988 -NZ$2.42 Million-0%
1987 -NZ$2.42 Million-46.15%
1986 -NZ$4.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Curis
CRIS
-NZ$56.27 Million 31.68%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-NZ$11.44 Million-73.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$14.24 B-33,443.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-NZ$0.24 Billion 458.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.06 B-7,266.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
NZ$55.99 B-131,127.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.28 B-768.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-NZ$16.4 Million-61.62%๐Ÿ‡บ๐Ÿ‡ธ USA